Drugs / Fluticasone furoate (FF)/Vilanterol (VI)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04750603 Comparator | Dec 2018 → Jan 2020 | childhood onset asthma | Rambam Health Care Campus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone furoate (FF)/Vilanterol (VI) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04750603 ↗ |
| Route | Inhaled | “Relvar® (Fluticasone furoate (FF)/Vilanterol (VI)) is a once daily inhaler” NCT04750603 ↗ |